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TheH3K4me3mark in chromatin is closely correlated
with actively transcribed genes, although themecha-
nisms involved in its generation and function are not
fully understood. In vitro studies with recombinant
chromatin and purified human factors demonstrate
a robust SET1 complex (SET1C)-mediated H3K4 tri-
methylation that is dependent upon p53- and p300-
mediated H3 acetylation, a corresponding SET1C-
mediated enhancement of p53- and p300-dependent
transcription that reflects a primary effect of SET1C
through H3K4 trimethylation, and direct SET1C-
p53 and SET1C-p300 interactions indicative of a tar-
geted recruitment mechanism. Complementary cell-
based assays demonstrate a DNA-damage-induced
p53-SET1C interaction, a corresponding enrichment
of SET1C and H3K4me3 on a p53 target gene
(p21/WAF1), and a corresponding codependency
of H3K4 trimethylation and transcription upon p300
and SET1C. These results establish a mechanism in
which SET1C and p300 act cooperatively, through
direct interactions and coupled histone modifica-
tions, to facilitate the function of p53.
INTRODUCTION
The transcription networks that underlie many physiological
processes are controlled by sequence-specific DNA-binding
transcription factors. These factors act in part through the
recruitment of diverse cofactors that generate specific histone
modification signatures, some involving histone crosstalk, asso-
ciated with gene activation or repression events (Suganuma and
Workman, 2011; Young, 2011). Modified histones in turn may
alter transcription through direct effects on chromatin structure
or through recruitment of other effectors (Patel and Wang,2013). Of special interest here, two modifications closely corre-
lated with gene activation are H3 acetylation and H3K4 methyl-
ation (Kouzarides, 2007; Li et al., 2007).
In human cells, H3K4 methylation is catalyzed by the SET1/
MLL family (SET1A, SET1B, MLL1, MLL2, MLL3, and MLL4) of
histone methyltransferases (HMTs). Like the prototype yeast
Set1 (Shilatifard, 2012), the human SET1/MLL proteins exist in
multiprotein complexes that possess both unique subunits and
common subunits (WDR5, RbBP5, ASH2L, and DPY30) related
to those in yeast COMPASS/Set1C (Vermeulen and Timmers,
2010). Biochemical studies have shown that human SET1/MLL
complexes possess variable intrinsic abilities to catalyze
mono-, di-, and trimethylation of H3K4, although, intriguingly,
these complexes appear to have largely nonredundant roles
(Eissenberg and Shilatifard, 2010). Notably, however, SET1C
appears responsible for the majority of H3K4 trimethylation in
mammalian cells (Shilatifard, 2012).
Genome-wide studies have shown that H3K4me3 is localized
mainly to promoter regions, whereas H3K4me1 is enriched at
enhancers (Heintzman et al., 2007; Zhou et al., 2011), raising
the general question of whether these events are mediated by
distinct enzymes or by position-specific activities of a common
enzyme. Thus, distinct recruitment and/or enzymatic regulatory
mechanisms for SET1/MLL complexes might be critical for the
position-specific distribution of the distinct methylation states.
A variety of alternative (nonmutually exclusive) mechanisms for
recruitment (or stabilization) of SET1/MLL complexes have
been described (reviewed in Ruthenburg et al., 2007; Schuetten-
gruber et al., 2011; Smith and Shilatifard, 2010), with recruitment
by sequence-specific DNA-binding transcription factors (Goo
et al., 2003; Vermeulen and Timmers, 2010) being of special
interest here. Position-specific H3K4 methylation states might
also be regulated by other factors, including other (local) histone
modifications. In this regard, early studies in yeast reported that
H2B ubiquitylation, which is generally coupled to transcription, is
essential for H3K4 trimethylation, but not H3K4 monomethyla-
tion, by COMPASS/Set1C (Shilatifard, 2012), whereas more
recent studies have shown that ubiquitylated H2B directlyCell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc. 297
stimulates H3K4 trimethylation of chromatin templates by the
human and yeast SET1 complexes (Kim et al., 2009, 2013).
As a transcription factor, the tumor suppressor p53 is tightly
regulated by complex mechanisms, which include various co-
valent modifications, in response to distinct cellular stresses
(Kruse and Gu, 2009; Vousden and Prives, 2009). Although
p53 is well studied with respect to its regulation, the mecha-
nisms by which it differentially activates target genes through
interactions with various cofactors, in particular those that effect
epigenetic changes in chromatin, are less well understood.
However, in relation to the H3K4 methylation mechanisms of
interest here, previous studies have demonstrated DNA-dam-
age-induced accumulation of H3K4me3, as well as other his-
tone modifications, on p53 target genes (An et al., 2004; Lee
et al., 2009).
To further investigate the factors and mechanisms involved
in p53-dependent H3K4 methylation, we have employed cell-
free systems reconstituted with purified factors and recombinant
chromatin templates in conjunction with cell-based assays of a
p53-dependent DNA-damage response. Our results establish
a p53-p300/H3ac-SET1C interaction network that leads to
synergistic SET1C and p300 functions in H3K4 methylation
and transcription activation and, overall, insights into underlying
mechanisms.
RESULTS
Human SET1C-Mediated H3K4 Trimethylation on
Recombinant Chromatin Is Strongly Enhanced by p53-
and p300-Dependent H3 Acetylation in the Absence of
H2B Ubiquitylation
SET1C was purified to near homogeneity through Flag-tagged
subunits (CFP1, WDR82, or SET1A) unique to SET1 complexes
(Figure S1 available online). In an initial analysis of their HMT
activities, these complexes exhibited clear H3K4 mono-, di-,
and trimethylation activities on recombinant histone octamer
substrates (Figure S2A) but very low activities on recombinant
chromatin substrates (data not shown). In view of reports of
enhanced H3K4 methylation of acetylated H3 peptides by an
isolated MLL1 SET domain (Milne et al., 2002; Nightingale
et al., 2007), as well as H3K4 methylation in the absence
(Wang et al., 2009) or near absence (Vethantham et al., 2012)
of H2B ubiquitylation in some physiological situations, we tested
the ability of p300-mediated histone acetylation to increase the
activity of SET1C on histone octamers with unmodified H2B
but found no effects (data not shown).
We next tested possible effects of histone acetylation onH3K4
methylation by SET1C in the more physiological context of a
p53- and p300-activated recombinant chromatin template (Fig-
ures 1A and S3) according to the protocol (An and Roeder,
2004) in Figure 1A. The histone acetyltransferase (HAT) assay
revealed robust p53- and p300-dependent acetylation of H3
(Figure 1B, lane 1 versus lane 2), as reported (An et al., 2004),
but failed to reveal any HAT activity in the SET1C preparation
(lanes 9 and 10) or any effect of SET1C on p300-dependent his-
tone acetylation (lane 2 versus lane 5). An immunoblot revealed
p53- and p300-dependent H3K18 and H3K27 acetylation that
was unaffected by SET1C (Figure 1C).298 Cell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc.In the HMT assay with recombinant chromatin (Figure 1D), a
low level of H3 methylation that was observed with SET1C alone
was increased about 3-fold with addition of p53 alone (lane 2
versus lane 1), only marginally with addition of p300/acetyl coen-
zyme A (acetyl-CoA) alone (lane 7 versus lane 1), and more
dramatically (10-fold) with the joint addition of p53 and p300/
acetyl-CoA (lane 1 versus lane 6). These methylation activities
were not observed in recombinant chromatin assembled with
an H3K4Q mutant (Figure 1D, lanes 11 to 14), indicating that
the observed SET1C-mediated H3 methylation is specific to
H3K4. In reactions without acetyl-CoA (Figure 1D, lane 5 versus
lane 2), the p53-enhanced H3K4 methylation activity of SET1C
was inhibited, rather than enhanced, by p300. This result likely
reflects direct p300-SET1C interactions that are described
below. In a further analysis with methylation state-specific anti-
bodies, and consistent with the results of Figure 1D, SET1C
alone generated only low levels of H3K4me2 and H3K4me3
that were minimally stimulated by single additions of p53 or
p300 but dramatically enhanced by their joint addition (Fig-
ure 1E). In confirmation, a mass spectrometric (MS) analysis of
the methylated H3 products from parallel reactions indicated
comparably high levels of H3K4me3 and H3K4me2 and a
much lower level of H3K4me1 (Figures 1G and 1H).
To confirm a role for histone acetylation per se in the p53- and
p300-dependent stimulation of H3K4 methylation by SET1C, we
assembled recombinant chromatin templates with mutant H3
(H3KR) or H4 (H4KR) containing lysine-to-arginine mutations at
known acetylation sites and, as a control, with the H3K4Q
mutant (Figure S3G). Notably, the H3KR substrate showed
increased levels of H3K4 monomethylation and nearly normal
levels of H3K4 dimethylation but drastically reduced levels of
H3K4 trimethylation, whereas the H4KR substrate showed
nearly normal levels of H3K4 mono-, di-, and trimethylation (Fig-
ure 1F). As a control, H3K27 acetylation was unaffected in the
H3K4Q and H4KR chromatin substrates but eliminated in the
H3KR chromatin substrate. Based on quantitation of the data
in Figure 1F (Figure 1I), and comparisons of the relative levels
of mono-, di-, and trimethylation by the immunoblot and MS an-
alyses in control (wild-type [WT] H3) reactions, themajor effect of
the H3KR mutations is on H3K4 trimethylation. These results
clearly establish a critical role for H3 acetylation, but not H4 acet-
ylation, in the p300-dependent enhancement of H3K4 trimethy-
lation by SET1C. In further support of primary effects of p300
through histone acetylation, rather than p53 acetylation (Kruse
and Gu, 2009), p53 mutations (Figures S4A and S4B) that effec-
tively eliminated p53 acetylation by p300 had no significant
effects on histone acetylation by p300 or p53/p300-dependent
H3K4 methylation by SET1C (Figure S4C). Related analyses
failed to show any acetylation of SET1C by p300 or methylation
of p53 or p300 by SET1C (Figure S4D).
Interestingly, at comparable inputs based on methyltransfer-
ase activities on histone octamers and immunoblots of common
subunits (Figures S2B and S2C), MLL3/4 complexes (purified
through either Flag:PA1 or Flag:UTX subunits) effected pre-
dominantly H3K4monomethylation and (to a lesser extent) dime-
thylation, but only very low levels of H3K4 trimethylation, in the
presence of p53 and p300 (Figure 1E); and the MLL3/4C-medi-
ated H3K4 monomethylation was dependent upon the presence
Figure 1. Human SET1C-Mediated H3K4 Trimethylation Is Stimulated by p53- and p300-Dependent H3 Acetylation on Recombinant
Chromatin Templates
(A) HAT and HMT assay scheme for p300 and SET1C.
(B) HAT assay with indicated factors and 3H-acetyl-CoA (autoradiographic analysis). Lower panels in (B) and (D) show loading controls stained with Coomassie
brilliant blue (CBB).
(C) H3 site-specific HAT assays with indicated factors and acetyl-CoA (immunoblot analysis with antibodies indicated on the left).
(D) HMT assays with indicated factors, chromatin substrates, and 3H-SAM (autoradiographic analysis).
(E) H3K4 methylation state-specific HMT assays with indicated factors (immunoblot analysis with antibodies indicated on the left).
(F) HAT and HMT assays with indicated factors and chromatin templates assembled with the mutant H3 and H4 histones indicated at the top and detailed in
Figure S3 (immunoblot analysis with antibodies indicated on the right).
(G–I)MSanalysis of p53- andp300-dependentmethylationproductsgeneratedbySET1CandhMLL3/4C (f:PA1C) onchromatinwithWThistones (as inE;Gshows
raw data values, and H shows plotted values) or by SET1C on chromatin with WT or mutant histone (H3KR or H4KR) octamers (as in F; I shows plotted values).
See also Figures S1, S2, S3, S4, and S6.
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Figure 2. Role of the p300 Bromodomain in
Regulating Histone Acetylation, H3K4 Tri-
methylation, p300 Recruitment, and SET1C
Recruitment on Recombinant Chromatin
(A) Schematic representation of p300 domains.
(B) HAT and HMT assays as indicated, with either
(1) p300 WT or p300 Dbromo with ACF1 WT-
assembled chromatin or (2) p300 WT with either
ACF1 Dbromodomain- or ACF1 Dbromodomain/
DPHD-assembled chromatin. Analysis was by
immunoblot with indicated antibodies (right).
Analyses in (B)–(E) according to Figure 1A.
(C) HAT assays in the presence of p53, 3H-acetyl-
CoA, and normalized amounts (Figure S3F)
of either p300 WT, p300 Dbromo, or p300 DY.
Analysis of HAT activities was by autoradio-
graphy (*nonspecific signal), and H3 inputs by
immunoblot.
(D) In vitro ChIP assays for SET1C recruitment
and H3K4 trimethylation in the presence of p53,
indicated p300 proteins, and acetyl-CoA. Anal-
ysis by real-time PCR from the indicated loca-
tions (Figure S3C) on the chromatin template.
Error bars in (D) and (E) denote standard
deviations (SD).
(E) In vitro ChIP assays for recruitment of SET1C
and p300 in the presence of the indicated
components. Analysis at the indicated locations
(Figure S3C) was by real-time PCR.
(F) Reciprocal coimmunoprecipitation of p300
and SET1C from nuclear extract by indicated
antibodies (top) followed by immunoblots with
indicated antibodies (right).
(G) Analysis of purified SET1C binding to re-
combinant p300 WT or p300 Dbromo (top)
monitored by immunoblot with indicated anti-
bodies (right).
(H) Analysis of Flag-p300 binding to individually
coexpressed SET1C subunits (monitored by
immunoblot with indicated antibodies).
(I) Analysis of purified Flag-ASH2L binding to
recombinant GST-p300 domains (monitored by
anti-Flag [M2] immunoblot).
See also Figures S1, S3, and S4.of p53 and p300 (Figure S2D). These results were confirmed by
MS analysis of MLL3/4C reaction products relative to the SET1C
reaction products (Figures 1G and 1H). A reconstituted core
MLL1 complex (Dou et al., 2006) exhibited similar properties
under these conditions (data not shown).
H3 Acetylation-Dependent H3K4 Trimethylation
Involves Histone Acetylation-Dependent Recruitment of
p300, through Its Bromodomain, and p300-Mediated
Recruitment of SET1C through Direct Interactions
Previous studies have demonstrated interactions of chromatin-
modifying factors, through bromodomains, with acetylated his-
tone residues (Filippakopoulos and Knapp, 2012). Therefore,
and given the absence of bromodomains in SET1C subunits,
we assessed the possible function of the bromodomain in the
ACF1 subunit of the ACF complex, whichwas used for chromatin
assembly and retained in the assay (Figure 1A), and the bromo-300 Cell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc.domain in p300 (Figure 2A). The bromodomain-deleted ACF1
was functionally equivalent to intact ACF1 in our assay (Fig-
ure 2B). Most importantly, however, a bromodomain-deleted
p300 mutant (p300 Dbromo, Figure S3F) that retained its autoa-
cetylation and p53 acetylation capabilities (Figure 2C) failed to
elicit either H3 acetylation or SET1C-mediated H3K4 trimethyla-
tion on recombinant chromatin (Figure 2B). As expected, a cata-
lytically inactive p300mutant (p300 DY, Figure S3F) also failed to
support either histone acetylation (Figure 2C) or SET1C-medi-
ated H3K4 trimethylation (data not shown). The loss of histone
acetylation by p300 Dbromo is consistent with its reported defi-
ciency in chromatin-based transcription (Santoso and Kado-
naga, 2006) and in acetylation of nucleosomal histones (Kraus
et al., 1999), whereas the loss of SET1C-mediated H3K4 trime-
thylation is consistent with our demonstration of histone acetyla-
tion-dependent methylation by SET1C. These results led us to
further explore the mechanistic aspects of p300 and its resident
bromodomain in both H3 acetylation and subsequent H3
methylation.
As the recruitment of p300 and SET1C to the promoter is
a key aspect of acetylation and methylation mechanisms, we
employed in vitro chromatin immunoprecipitation (ChIP) assays
to explore their position-specific recruitment to the recombi-
nant chromatin template. As shown in Figure 2D, SET1C and
H3K4me3 marks were selectively localized to the adjacent
TATA-box and p53-binding-site regions relative to the flanking
5S nucleosome-positioning sequences (Figure S3C). Notably,
and in agreement with the methylation data in Figure 2B,
SET1C recruitment and accumulation of H3K4me3 were abro-
gated by deletion of the p300 bromodomain. In additional
analyses, a low level of site-specific SET1C binding that was
marginally enhanced by p53 was dramatically enhanced by
p300 and, indicative of a histone acetylation requirement,
dependent upon acetyl-CoA (Figure 2E, left panel). Similarly,
p300 recruitment in the presence of acetyl-CoA was dependent
upon p53, consistent with previous reports of direct inter-
actions (An et al., 2004), and, somewhat surprisingly, signifi-
cantly enhanced by the presence of SET1C (Figure 2E, right
panel). Notably, the SET1C-enhanced p300 binding (Figure 2E,
right) and the p53-dependent/SET1C-independent binding of
p300 (data not shown) to the promoter were completely depen-
dent upon the presence of acetyl-CoA—again indicative of
a role for histone acetylation in both p300 and SET1C
recruitment.
Although these results clearly indicated roles for p300 inter-
actions with p53 and with acetylated histones (through the
bromodomain) in p300 recruitment and stabilization, they left
open the molecular basis for SET1C recruitment. Although
studies described below document a direct p53 interaction as
part of the SET1C recruitment mechanism, we also explored
the possibility of a direct p300-SET1C interaction in light of
the above-mentioned effect of SET1C on p300 binding. In sup-
port of this possibility, p300 was coimmunoprecipitated from
HeLa nuclear extract by antibodies to ASH2L (common subunit
of SET1/MLL complexes) and CFP1 (SET1C-specific) but much
more weakly by an antibody to NCoA6 (MLL3/4C-specific),
and, reciprocally, ASH2L was coimmunoprecipitated with
anti-p300 (Figure 2F). As a control, the MED17 mediator sub-
unit was not coimmunoprecipitated by any of these antibodies.
In a more definitive analysis that clearly demonstrates a direct
p300-SET1C interaction, a purified SET1C complex was shown
to bind directly, and equivalently, to purified p300 WT and
p300 Dbromo (Figure 2G). These results also suggest that the
bromodomain requirement for SET1C promoter recruitment is
indirect—with the bromodomain being required for p300 stabi-
lization and p300, in turn, being required (through direct inter-
actions) for SET1C recruitment. In a further dissection of the
p300-SET1C interactions, p300 was found to selectively
interact with the ASH2L subunit of the SET1 complex (Fig-
ure 2H), and ASH2L was found to interact strongly with the
TAZ1 and TAZ2 domains of p300 and weakly with the KIX
and IBiD domains (Figures 2A and 2I). These results overall
argue strongly for roles for bromodomain-dependent p300-
acetylated histone and p300-SET1C interactions in SET1C
promoter recruitment and function.Human SET1C-Mediated H3K4 Trimethylation Markedly
Enhances p53- and p300-Dependent Transcription on
Recombinant Chromatin
To determine whether SET1C-mediated H3K4 trimethylation
directly facilitates p53-dependent transcription, either alone or
in conjunction with p300, we tested its effect on transcription
of recombinant chromatin according to the protocol in Fig-
ure 3A. This assay revealed a robust p53-dependent transcrip-
tional activation in the presence of p300/acetyl-CoA (Figure 3B,
lane 4 versus lane 3), as reported previously (An et al., 2004),
whereas SET1C/SAM alone failed to elicit any detectable
p53-dependent transcription (Figure 3B, lane 1 versus lane 2).
Remarkably, however, SET1C/SAM markedly increased the
p53-dependent transcription observed with p300/acetyl-CoA
(Figure 3B, lanes 2 and 4 versus lane 10). In contrast to the
results observed with SET1C, but consistent with its low
H3K4 trimethylation activity (Figure 1E), the MLL3/4 complex
failed to enhance p53- and p300-dependent transcription
(data not shown).
To further establish the function of H3K4 trimethylation by
SET1C in p53-dependent transcription, we analyzed chromatin
templates assembled with the mutant H3KR, H4KR, and
H3K4Q histones described above. p53- and p300-dependent
transcription was significantly reduced by the lysine-to-arginine
mutations in either H3 (H3KR) or H4 (H4KR), consistent with our
previous results (An et al., 2004), but not by the H3K4Qmutation
(Figure 3C, lanes 3, 5, and 7 versus lane 1). Most importantly,
however, the large SET1C enhancement of p53/p300-depen-
dent activity (lane 2 versus lane 1) was largely eliminated by
the H3K4Q mutation that precludes H3K4 methylation (lane 4
versus lane 2). This result indicates that the stimulatory effect
of SET1C is mediated mainly through H3K4 methylation,
whereas the residual SET1C-enhanced activity may reflect other
functions of SET1C such as the stabilization of p300 binding
observed in Figure 2E. We also observed significant levels of
transcription (above the nondetectable baseline levels) from
the H3KR and (most notably) H4KR templates (lane 6 versus 5
and 8 versus 7) in the presence of p53, p300, and SET1C, further
indicative of SET1C-mediated H3K4 trimethylation functions that
partially compensate for the loss of H3 or H4 acetylation-depen-
dent functions.
To further establish a direct role for H3K4 trimethylation
in p53- and p300-dependent transcription, we reconstituted
a recombinant chromatin template with a semisynthetic
methyl-lysine analog (H3Kc4me3) of H3K4me3 (Simon et al.,
2007) in place of unmodified H3. Consistent with the observed
effect of SET1C-mediated methylation on transcription, prein-
corporated H3Kc4me3 markedly enhanced p53- and p300-
dependent transcription in the absence of SET1C (Figure 3D,
lane 8 versus lane 2) but failed to elicit detectable transcription
in the absence of p53 or p300 (lanes 7 and 12). Moreover,
and further indicative of a predominant function of SET1C
through H3K4 trimethylation, the activity observed with the
H3Kc4me3 template was comparable to that observed with
SET1C (lane 8 versus lane 5) and not further enhanced by
addition of SET1C (lanes 8–11). (The small differential likely
reflects a lower level of substrate trimethylation in the SET1C
reactions [Figure 1H]). Two recent studies also reportedCell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc. 301
Figure 3. SET1C Facilitates p53- and p300-
Dependent Transcription on Recombinant
Chromatin through H3K4 Trimethylation
(A) Scheme for recombinant chromatin-based
transcription assays.
(B) Stimulation of p53-and p300-dependent tran-
scription by SET1C.
(C) Effects of H3 and H4 mutations on SET1C- and
p300-dependent transcription. Chromatin tem-
plates were reconstituted with either control (WT)
or indicated mutant histones (detailed in Fig-
ure S3G).
(D) Stimulation of p53- and p300-dependent
transcription by prior incorporation of semi-
synthetic H3Kc4me3 into the chromatin template.
Factor additions as indicated in (B)–(D). Autora-
diographs in (B), (C), and (D) were scanned and
quantitated by Quantity One Program (Bio-Rad).
See also Figures S1 and S3.stimulatory effects of H3Kc4me3 on activator-mediated tran-
scription from chromatin templates but did not investigate
effects of histone acetylation on H3K4 trimethylation or tran-
scription by endogenous SET1C (Lauberth et al., 2013; Lin
et al., 2011). Altogether, our biochemical studies establish
that SET1C-mediated H3K4 trimethylation plays a critical and
causative role in facilitating p53- and p300-dependent
transcription.302 Cell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc.Direct and Specific Physical
Interaction of SET1C with p53
Although the above-described studies
established a role for p300-SET1C inter-
actions in p53- and p300-dependent
H3K4 trimethylation and transcriptional
enhancement by SET1C, they also
indicated a modest (but significant)
stimulation of SET1C-mediated H3K4
methylation by p53 in the absence of
p300 (see also Figure S6 below). To
assess whether this reflects a direct
p53-SET1C interaction that might com-
plement the p53/p300-enhanced func-
tion of SET1C, we initially determined
whether endogenous p53 directly asso-
ciates with SET1C under physiological
conditions. As shown in Figure 4A (upper
panel), following treatment of HCT116
cells (a human colorectal cancer cell
line) with doxorubicin, an anti-CFP1
antibody coimmunoprecipitated p53 in
parallel to its induction. Coimmunopreci-
pitation of hSET1, RbBP5, and ASH2L
with anti-CFP1 indicated that the integ-
rity of SET1C was not affected by DNA
damage. A reciprocal coimmunoprecipi-
tation with an anti-p53 antibody also
revealed a doxorubicin-enhanced asso-
ciation of CFP1, SET1, and ASH2L withp53 (Figure 4A, middle panel). The lysate immunoblots of p53,
p21, RbBP5, and b-actin are shown as controls (Figure 4A,
lower panel). Quantitation of these data confirms a doxoru-
bicin-induced increase in the p53-SET1C association that paral-
lels the increase in the cellular level of p53 (Figure S5). In a
further analysis, p53 was selectively coimmunoprecipitated
from p53 WT HCT116 cells by both anti-SET1 and anti-CFP1
antibodies but not by IgG or an anti-MLL1 antibody that
Figure 4. Direct Doxorubicin-Induced Inter-
actions of p53 with SET1C in HCT116 Cells
(A) Doxorubicin-induced interaction of p53 with
endogenous SET1C. IPs (left) were monitored by
immunoblot with indicated antibodies (right).
(B) SET1C-specific interaction with p53. IPs (indi-
cated at the top) from doxorubicin-treated (16 hr)
p53WT and p53 null HCT116 cells weremonitored
by immunoblot with indicated antibodies (right).
(C) Direct binding of purified SET1C (monitored by
antibodies indicated on right) to p53.
(D) Scheme for DSP-mediated crosslinking of p53
to SET1C.
(E) CFP1-mediated intracellular association of
p53 with a reconstituted SET1C (details in the
Extended Experimental Procedures). See also
Figures S1 and S5.coimmunoprecipitated an equivalent level of the common
RbBP5 subunit (Figure 4B).
In a more direct analysis with purified proteins, SET1C bound
strongly toGST-p53 but not to GST (Figure 4C). Related, analysis
of a p53-associated SET1C (reconstituted in Sf9 cells) in a dithio-
bis[succinimidyl propionate] (DSP)-based crosslinking assay
(Figure 4D) revealed a dominant interaction of p53 with the
CFP1 subunit of SET1C (Figure 4E). These results clearly
establish a direct p53-SET1C interaction, primarily through the
SET1C-specific subunit CFP1, that may account for the
observed intracellular association of doxorubicin-induced p53
with SET1C.
SET1C and p300 Act Cooperatively to Regulate H3K4
Trimethylation and Transcription of a p53 Target Gene
in a DNA-Damage Response
Because H3K4me3 is enriched at the canonical p53 target gene
p21/WAF1 in HCT116 cells in response to DNA damage (Kim
et al., 2009, 2010), we chose this system for analysis of SET1C
function in vivo. In an initial analysis, a small interfering RNA
(siRNA)-based knockdown of either CFP1 or WDR82 (both
unique to SET1C) significantly reduced both global H3K4me3
(Figure 5A), as expected (Shilatifard, 2012), and, most impor-
tantly, the doxorubicin-induced enrichment of H3K4me3 at the
p21/WAF1 promoter (Figures 5B and 5C), whereas the global
levels of H3K18/27ac were not affected (Figure 5A). Notably,
the doxorubicin-induced expression of p21/WAF1 was dramati-Cell 154, 297–cally reduced, at both protein (Figure 5A)
and messenger RNA (mRNA) (Figure 5D)
levels, by knockdown of either CFP1 or
WDR82.
In view of the effects of p300-mediated
acetylation on H3K4 methylation in vitro
(Figure 1), we also tested the effects of
p300 depletion on p21/WAF1 activation
events in vivo. In an initial siRNA-based
approach (see also below), the knock-
down of p300 in doxorubicin-treated
HCT116 cells reduced the global levels
not only of the H3K18ac and H3K27ac(p300-specific marks) but also of H3K4me3 (Figure 5E). A
ChIP analysis also revealed a significant reduction in p21/
WAF1 promoter-associated H3K4me3 following p300 knock-
down (Figures 5B and 5C), correlating well with the biochemical
results (Figures 1D and 1E). Finally, the doxorubicin-induced
expression of p21/WAF1 was also significantly reduced upon
p300 knockdown (Figure 5E), consistent with previous results
(Iyer et al., 2004). The joint requirement of p300 and SET1C
(above) for doxorubicin-induced H3K4 methylation and expres-
sion of p21/WAF1 indicates a clear functional cooperativity
between these factors.
p53-Dependent Recruitment of SET1C and Enrichment
of H3K4me3 at the p21/WAF1 Gene during
DNA-Damage-Induced Transcription
Our demonstration of a direct physical interaction between
p53 and SET1C suggested that p53 may play a direct role,
complementary to that involving p300-SET1C interactions, in
facilitating recruitment of SET1C to specific regions in
the p21/WAF1 gene during a DNA-damage response. To
further test this hypothesis, we performed real-time PCR-
based ChIP assays, at the gene regions indicated in Fig-
ure 6A, at various times after exposure of HCT116 cells to
doxorubicin. These analyses revealed (1) significant doxoru-
bicin-induced enrichments of p53, H3K18ac, H3K27ac,
and H3K4me1 at the enhancer (Figures 6B–6E) and (2)
significant doxorubicin-induced enrichments of Pol II, the310, July 18, 2013 ª2013 Elsevier Inc. 303
Figure 5. p300 and SET1C Act Coopera-
tively to Regulate DNA-Damage-Induced
Transcription of the p21/WAF1 Gene by p53
(A) Effects of siRNA-based CFP1 and WDR82
knockdowns on global H3K4 methylation and
doxorubicin-induced p53 target gene (p21/WAF1)
expression in HCT116 cells. The asterisk indicates
a cross-reactive band. In (A) and (E), siRNA pools
are indicated at the top, and immunoblot anti-
bodies on the right. The instability of SET1A in the
absence of WDR82 was previously noted in yeast
and human cells.
(B) Diagram of the p21/WAF1 gene and PCR
amplicons used for ChIP analyses.
(C) Effects of siRNA-based p300, CFP1, and
WDR82 depletions on doxorubicin-induced (16 hr)
enrichment of H3K4me3 on 21/WAF1 in HCT116
p53+/+ cells. ChIP analysis at amplicons A through
F as indicated in (B).
(D) Effects of siRNA-based CFP1 and WDR82
depletions on p21/WAF1 expression in doxoru-
bicin-treated HCT116 p53+/+ cells. RNA levels
were monitored by real-time RT-PCR. Errors bars
in (C) and (D) denote SD from duplicate reactions
by real-time PCR.
(E) Effects of p300 knockdown on global H3K18/
27 acetylation and H3K4 methylation and on
expression of p21/WAF1.SET1C-specific subunit CFP1, and H3K4me3 at the promoter
(Figures 6F–6H). The doxorubicin-induced accumulation of
p53 and Pol II at p21/WAF1 enhancer and promoter ele-
ments, respectively, is consistent with results of a previous
study (Kim et al., 2010). Similarly, the differential distribution
of H3K4me1 and H3K4me3 to enhancer and promoter regions,
respectively, is consistent with previous genome-wide studies
in human cells (Heintzman et al., 2007). Thus, these results
suggest that p53 is instrumental in facilitating recruitment of
SET1C and a corresponding enrichment of H3K4me3 and
H3K4me1 at the p21/WAF1 gene upon DNA-damage-induced
transcription.
Depletion of p300 Leads to Significant Reductions
of SET1C and Both H3K4me1 and H3K4me3 at the
p21/WAF1 Gene in Response to DNA Damage
In a further analysis of doxorubicin-induced changes on p21/
WAF1, and taking advantage of HCT116 p300 WT and null
cells (Iyer et al., 2004), comparative ChIP analyses (Figure 6)
revealed (1) dramatic reductions of the doxorubicin-induced,
enhancer-associated H3K27ac and H3K18ac marks, as well as304 Cell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc.the H3K4me1 mark, in the p300 null cells
relative to p300 WT cells, (2) significant
reductions of the doxorubicin-induced
enrichments of SET1C and H3K4me3 at
the proximal promoter in p300 null cells,
and (3) significant, but less dramatic,
reductions in the doxorubicin-induced
enrichments of Pol II at the promoter
and p53 at the enhancers in p300 nullcells, the latter result indicating a stabilizing effect of histone
acetylation on p53 binding. Most importantly, the loss of both
CFP1/SET1C and the H3K4me3 and H3K4me1marks is strongly
correlated with the loss of p300 and related histone acetylation
events. Thus, these results provide strong support for the pro-
posal, from the more direct biochemical experiments, that
p300-mediated histone acetylation events play a key role
in SET1C-mediated H3K4 methylation events that are also
important for transcriptional activation of the p21/WAF1 gene
by p53.
Independent and Cooperative Effects of p300/H3
Acetylation and H2B Ubiquitylation on SET1C-Mediated
H3K4 Trimethylation
Beyond our demonstration of p53 and p300 interactions with
SET1C that facilitate its function in H2Bub-independent H3K4
methylation, we examined H2Bub-dependent H3 methylation
by SET1C by employing chromatin templates assembled
with either WT H2B or a semisynthetic H2Bub analog (Kim
et al., 2009, 2013). This analysis (Figure S6) revealed (1)
comparable basal (p53-independent) levels of trimethylation
Figure 6. Role of p300 in the DNA-Damage-Induced Accumulation of SET1C and H3K4me3 on the p21/WAF1 Gene
(A) Diagram of p21/WAF1 and PCR amplicons used for ChIP analyses.
(B–H) ChIP assays with the indicated antibodies at the indicated p21/WAF1 loci. Error bars in (B)–(H) denote the SD from duplicate reactions by real-time PCR
(all ChIP assays were repeated twice).activity with p300/acetyl-CoA versus H2Bub (lanes 2 and 5),
(2) comparable levels of p53-dependent activity with p300/
acetyl-CoA versus H2Bub (lanes 4 and 7), (3) cooperativity
between p300/acetyl-CoA and H2Bub in stimulating p53-
dependent H3K4 trimethylation by SET1C (lane 8 versus lanes
4 and 7), and (4) a large enhancement of SET1C activity by
p53 in the absence of p300/acetyl-CoA on the H2Bub-contain-
ing template (lane 7 versus lane 5), an observation that strongly
supports a proposed complementary role for the direct
p53-SET1C interaction in SET1C recruitment. Most impor-
tantly, the quantitatively comparable effects of H2B ubiquityla-
tion and p300/acetyl-CoA on SET1C activity, as well as theircooperativity, suggest that they may be equally important
in vivo.
DISCUSSION
A variety of genetic and biochemical studies have provided
important examples of crosstalk between different histone mod-
ifications (Lee et al., 2010; Suganuma and Workman, 2011).
Here, in relation to p53-dependent transcription, we have estab-
lished strong physical and functional linkages between p300 and
SET1C and their corresponding histone modifications. These
results, discussed below, have revealed mechanistic insightsCell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc. 305
into the regulation of H3K4 methylation that are likely of broad
significance.
Histone Crosstalk: A Cooperativity between p300 and
SET1C that Parallels and Complements Cooperativity
between Ubiquitylated H2B and SET1C
Although there are a number of prior examples of histone cross-
talk (Lee et al., 2010; Suganuma and Workman, 2011), most of
these have been inferred either from cell-based assays, where
indirect effects or secondary contributions of other endogenous
histone modifications are hard to rule out, or from in vitro assays
with nonphysiological substrates (e.g., histone peptides or iso-
lated mononucleosomes) and enzymes (e.g., isolated catalytic
domains or catalytic subunits of larger complexes). In the pre-
sent case, our in vitro assays with unmodified recombinant chro-
matin clearly establish a direct effect of p300-dependent H3
acetylation and subsequent p300 stabilization (discussed below)
on H3K4 trimethylation by SET1C. Importantly, our complemen-
tary cell-based assays lend further support to the notion of a
direct role for p300-dependent H3 acetylation and associated
p300 stabilization in SET1C-mediated H3K4 trimethylation (dis-
cussed further below).
It is noteworthy that the p53- and p300-dependent H3K4
trimethylation observed in our defined in vitro system occurs
independently of any H2B ubiquitylation. Hence, although H2B
ubiquitylation is critical for H3K4 trimethylation by COMPASS/
Set1C in yeast (Shilatifard, 2012) and can enhance H3K4 trime-
thylation by both human (Kim et al., 2009) and yeast (Kim et al.,
2013) SET1 complexes on unacetylated nucleosomal sub-
strates, our results clearly demonstrate an intrinsic ability of
SET1C to effect significant H3K4 trimethylation, in conjunction
with p53 and p300, in the absence of H2B ubiquitylation. This
result is consistent with H3K4 methylation in the absence of
H2B ubiquitylation in Tetrahymena (Wang et al., 2009) and
normal levels of H3K4 trimethylation in yeast (Lee et al., 2012)
and in differentiated myoblasts (Vethantham et al., 2012) at
very low levels of H2Bub. Notably, as p53 and p300 functions
may be more closely associated with enhancer/promoter func-
tions and transcription initiation, whereas H2B ubiquitylation
appears to be associatedwith and dependent upon transcription
elongation (Kim et al., 2009), our results raise the possibility of
partially distinct functions, in initiation and elongation, of the
two SET1C regulatory mechanisms. Nonetheless, our demon-
stration of cooperative effects of p300 and H2Bub on SET1C
activity in vitro leaves open the possibility of cooperative intra-
cellular functions in initiation and/or elongation.
The p300 Bromodomain Links Histone Acetylation and
H3K4 Trimethylation by Stabilizing p300 for Subsequent
SET1C Recruitment through Direct Interactions
Interactions of histone acetyl-lysine residues with the bromodo-
mains of chromatin remodeling and transcription factors are
thought to play key roles in the recruitment and/or function of
these factors (Filippakopoulos and Knapp, 2012). Here, our
in vitro analyses have demonstrated (1) that the p300 bromodo-
main is important not only for histone acetylation by p300, as
previously reported (Kraus et al., 1999), but also for H3K4 trime-
thylation by SET1C, (2) that the p300 bromodomain-dependent306 Cell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc.histone acetylation is actually required, along with p53, for the
stable association of p300 with the chromatin template, (3) that
the stable association of SET1C with the template is dependent
upon both p300 and the bromodomain-dependent histone
acetylation, and, related, (4) that SET1C, through its ASH2L sub-
unit, interacts directly with p300 through its TAZ domains, thus
providing a clear mechanism for the p300-dependent recruit-
ment and function of SET1C. These in vitro results lead to a
model (Figure 7) in which the first important feature is an initial
p53-mediated recruitment of p300 that is stabilized by primary
p300-mediated acetylation events, which in turn lead to a feed-
forward mechanism for p300-mediated histone acetylation that
could ultimately become independent of p53. A similar situation
has been described for the recruitment and function of the yeast
SAGA complex (Hassan et al., 2002). The second important
feature is the p300-enhanced recruitment of SET1C, which is
complementary to the p53-based recruitment and leads directly
to H3K4 trimethylation. These results thus add another important
mechanism, namely interactions with the coactivator p300, to
the growing list of mechanisms (reviewed in Smith and Shilati-
fard, 2010; Schuettengruber et al., 2011) for recruitment of
SET1/MLL complexes.
Dominant Function of SET1C, Relative to MLL
Complexes, in H3K4 Trimethylation Is Related to p53-
and p300-Dependent Transcription
The existence of a family of SET1C-related complexes in
mammalian cells (see Introduction) raises significant questions
regarding the complexes’ potential gene- and cell-specific func-
tions, as well as their intrinsic capabilities for mono-, di-, and tri-
methylation. Here, we demonstrate that a highly purified SET1C,
in a p53- and p300-dependent manner, exhibits a high degree of
H3K4 tri- and dimethylation relative to monomethylation,
whereas related MLL1 and MLL3/4 complexes show the oppo-
site behavior. Consistent with this observation, and a major
role for SET1C in p53 target-gene activation, depletion of
SET1C-specific subunits (WDR82 or CFP1) significantly reduced
H3K4me3 both on the p53-activated p21/WAF1 gene and, as
expected (Shilatifard, 2012), at a global level. Consistent with
our results, a recent study showed a global decrease of
H3K4me3 upon depletion of p300/CBP in mouse embryonic
fibroblasts (MEFs) but did not establish either the responsible
methyltransferase or a direct effect of acetylation on methylation
(Jin et al., 2011).
Consistent with the existence of a family of related SET1/MLL
enzymes and corresponding complexes in mammalian cells,
there is increasing evidence for selective (nonredundant)
functions for these enzymes (Eissenberg and Shilatifard, 2010;
Vermeulen and Timmers, 2010). However, it remains to be
determined whether these enzymes may function cooperatively
on most genes—for example, at promoters versus enhancers, at
different steps (initiation versus elongation) in the transcription
cycle, or in effecting different states of H3K4 methylation.
Thus, whereas our present results clearly establish a major role
for SET1C in p53- and p300-dependent H3K4 trimethylation
in vitro and in vivo, they do not exclude a secondary role for a
SET1C-related MLL complex in p53 function. In this regard,
recent studies have demonstrated (1) roles for both SET1A and
Figure 7. Model for Cooperative p300 and
SET1C Functions, Involving Direct Recruit-
ment by p53 and Coupled Histone Modi-
fications, in Facilitating p53-Dependent
Transcription In Vitro
Based on in vitro biochemical analyses, the
following model is proposed: (1) site-specific
binding of p53, (2) p53-mediated recruitment of
p300 with concomitant H3 acetylation and further
stabilization of p300 through bromodomain
interactions with acetylated H3 residues, (3) p53-
mediated recruitment of SET1C, which in turn is
stabilized by direct interactions with p300, and
subsequent H3K4 trimethylation at the promoter
by SET1C, and (4) functions of the histone acetyl
and H3K4me3 marks in the recruitment and
function of downstream effector molecules (not
indicated), leading to the formation and function of
initiation and elongation complexes.
See text for details and relevance to DNA-dam-
age-induced activation of p53 target genes in
cells. See also Figure S7.MLL1 in activation of specific estrogen receptor target genes
(Jeong et al., 2011), (2) a role for the Drosophila homolog (Trr)
of MLL3/4 in the genome-wide maintenance of H3K4 monome-
thylation on enhancers (Herz et al., 2012), and, of most relevance
here, (3) roles for MLL3 (Lee et al., 2009) and MLL4 (Guo et al.,
2012) in p53 function in cell-based assays—including localiza-
tion of MLL3/4C to the p21/WAF1 enhancer in MEF cells (Lee
et al., 2009) as discussed below.
Direct Role for p53, as well as p300, in Mediating SET1C
Recruitment and Function
Although studies in yeast have emphasized transcription-
dependent recruitment mechanisms (Shilatifard, 2012), clear
evidence exists for alternative or complementary mechanisms
in mammalian cells (reviewed in Smith and Shilatifard, 2010;
Schuettengruber et al., 2011). Here, our demonstration of a
low but significant p53-dependent H3K4 trimethylation by
SET1C on recombinant chromatin templates in the absence
of p300 and, especially, a direct interaction between p53 and
SET1C argues strongly for a direct recruitment of SET1C by
enhancer/promoter-bound p53 that parallels the previouslyCell 154, 297–reported p300 recruitment by p53 (An
et al., 2004). Although these biochemical
studies provide the best evidence for
this mechanism, it is strongly supported
by cell-based assays that show a DNA-
damage-induced intracellular associa-
tion of p53 and SET1C extrinsic to the
chromatin template. Importantly, the
ChIP assays in p300 WT versus p300
null HCT116 cells, which show that
the loss of p300 and accompanying
H3 acetylation has a much greater
effect on SET1C recruitment and H3K4
methylation than on p53 binding, also
suggest a role for p300-dependent his-tone acetylation in SET1C recruitment or stabilization. These
results are consistent with the in vitro ChIP data showing that
SET1C recruitment is highly dependent on both p53 and
p300. Thus, as discussed earlier, we favor a mechanism in
which SET1C is initially recruited (targeted) by p53 but subse-
quently stabilized by its interaction with p300 (Figure 7). This
type of two-step mechanism has also been proposed for the
recruitment and stabilization of other chromatin-modifying fac-
tors (Ruthenburg et al., 2007; Suganuma and Workman, 2011).
In further support of the proposed mechanism for SET1C
recruitment by p53, several studies have reported interactions
of DNA-binding transcription factors with SET1C-related MLL
complexes (Goo et al., 2003; reviewed in Vermeulen and Tim-
mers, 2010) but, unlike the present study, did not establish
direct roles for specific histone modifications in facilitating the
recruitment or function of these complexes. In relation to our
demonstration that p300 interacts with SET1C through its
ASH2L subunit, which is common to all SET1/MLL complexes,
it is interesting that ASH2L also plays an important role in
H2Bub-mediated H3K4 methylation by the MLL1 complex
in vitro (Wu et al., 2013).310, July 18, 2013 ª2013 Elsevier Inc. 307
Causal Role for SET1C-Mediated H3K4 Trimethylation
in p53-Dependent Transcription
Although H3K4 trimethylation has been correlated with actively
transcribed or poised genes in organisms ranging from yeast to
human, its depletion has little effect on global gene expression
in yeast, where it appears to be mainly a consequence rather
than a cause of transcription (Shilatifard, 2012), or on transcrip-
tion of H3K4me3-marked pluripotency genes in embryonic
stem cells (ESCs) (Jiang et al., 2011). On the other hand,
demonstrations of effects of H3K4me3 depletion on expression
of specific genes (Goo et al., 2003; Jiang et al., 2011; Shilati-
fard, 2012) and of H3K4me3 recognition by various transcrip-
tion factors and chromatin-remodeling factors (Ruthenburg
et al., 2007; Vermeulen and Timmers, 2010) have indicated
functions (some potentially indirect) on transcription of specific
genes. In this report, a causal role for SET1C-mediated
H3K4 trimethylation in p53-dependent transcription is clearly
established by (1) the enhancement of p53- and p300-
dependent transcription by a purified SET1C complex in a
cell-free system reconstituted with a recombinant chromatin
template containing a single promoter/enhancer, (2) the loss
of this SET1C-enhanced transcription on a chromatin tem-
plate reconstituted with an H3K4Q mutant, and (3) the quanti-
tative recapitulation of this SET1C-enhanced transcription (in
the absence of SET1C) by prior incorporation of H3Kc4me3
into the chromatin template. Our demonstration of SET1C-
dependent transcription of the endogenous p53- and p300-
activated p21/WAF1 gene in HTC116 cells further supports
this conclusion. Moreover, in contrast to the less definitive
cell-based analysis of endogenous genes, the in vitro assays
also indicate that robust SET1C-enhanced H3K4 methylation
does not depend, intrinsically, upon histone modifications
other than those generated by p300. However, this does not
preclude positive effects of other histone modifications,
including H2Bub (discussed above) and the recently described
H3R2 symmetric dimethylation (Migliori et al., 2012), on H3K4
methylation.
H3K4Methylation and H3 Acetylation Events in Relation
to Enhancer-Promoter Interactions and a Simplified
Model
Our in vitro analyses with a model template lead to a simple
model (Figure 7) in which enhancer/promoter-bound p53,
through direct interactions, recruits p300 and SET1C to effect
linked H3 acetylation and H3K4 trimethylation events through
additional p300-SET1C interactions (as discussed earlier) at
the contiguous enhancer-core promoter region. Interactions of
these histone marks with other effectors (Ruthenburg et al.,
2007; Vermeulen and Timmers, 2010) may then stimulate later
steps in transcription. Importantly, our in vivo analyses are
consistent with the in vitro results with respect to corresponding
p300 and SET1C requirements, colocalization of SET1C and
H3K4me3, and colocalization of H3K4me1 and H3K27ac
marks. However, they present a more complicated situation
related to the promoter-distal localization of the enhancer in
the natural p21/WAF1 gene. Thus, although we presume
from the various in vitro results that enhancer-bound p53 and
p300 are involved in the DNA-damage-induced recruitment of308 Cell 154, 297–310, July 18, 2013 ª2013 Elsevier Inc.SET1C to the p21/WAF1 gene in vivo, the DNA-damage-
induced SET1C and H3K4me3 marks localize primarily to the
promoter, whereas the induced H3K4me1 and H3K18ac/
H3K27ac marks localize mainly to the enhancer. These results
raise the possibility of dynamic enhancer-promoter interactions,
potentially involving chromatin looping (Young, 2011), that
result in primary transient interactions of SET1C at the enhancer
with transfer and subsequent stabilization and function at the
promoter in the steady-state situation (Figure S7). In apparent
support of this model, a recent study has documented accumu-
lation of SET1C and H3K4me3 at p300-associated enhancer
elements upon mutation of the CFP1 CXXC domain that,
through CpG interactions, normally restricts stable SET1C bind-
ing to promoters (Clouaire et al., 2012). Related, the exact origin
of the p21/WAF1 enhancer-localized H3K4me1 mark remains
unclear. One possibility is acetylated H3-dependent monome-
thylation by SET1C, with processivity restricted by other local
factors. Another possibility, as discussed earlier, is monome-
thylation by a SET1C-related MLL complex such as MLL3/4
(Figure S7). Noteworthy in this regard are (1) our demonstration
that p53- and p300-dependent H3K4 methylation of a chro-
matin template by the MLL3/4 complex results primarily in
monomethylation, (2) our demonstration that p21/WAF1
enhancer monomethylation in doxorubicin-induced HTC116
cells, like the MLL3/4-mediated H3K4 monomethylation
in vitro, is also dependent upon p300 (and potentially p300-
ASH2L/MLLC interactions), and, as mentioned above, (3) a
prior localization of MLL3/4C to the p21 enhancer in doxoru-
bicin-treated MEFs (Lee et al., 2009). Thus, despite current
uncertainty about the mechanisms involved in H3K4 monome-
thylation at the p21/WAF1 and other enhancers, our results
add major insights into mechanisms that underlie p300-depen-
dent H3K4 trimethylation by SET1C at the p21/WAF1 promoter
and that may be relevant to H3 acetylation and H3K4 monome-
thylation at the enhancer.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection
HCT116 cells were cultured, treated with doxorubicin, and transfected with
siRNAs as described (Kim et al., 2009). Stable cell lines expressing Flag-
tagged SET1C subunits were established by standard methods detailed in
the Extended Experimental Procedures.
Recombinant Proteins and SET1/MLL Complexes
Recombinant histones, chromatin-assembly factors, p53, and p300 were pre-
pared as described (An et al., 2004). Methyl-lysine analogs in H3 were installed
as described (Simon et al., 2007). Human SET1/MLL complexes were affinity
purified as detailed in the Extended Experimental Procedures.
Recombinant Chromatin Assembly andHAT, HMT, and Transcription
Assays
All assays were performed as previously described (An et al., 2004; Kim et al.,
2009), and as outlined in Figure 3A, with modifications detailed in the Extended
Experimental Procedures.
Protein Binding, Coimmunoprecipitation, ChIP, and RT-PCR Assays
Assays were performed as previously described (Kim et al., 2009), with
modifications and relevant antibodies detailed in the Extended Experimental
Procedures. The p53-SET1C crosslinking analysis with DSP is also detailed
in the Extended Experimental Procedures.
Mass Spectrometry
H3K4 methylated products were analyzed by standard liquid chromatog-
raphy-tandem MS (LC-MS/MS) as detailed in the Extended Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, seven
figures, and one table and can be found with this article online at http://dx.doi.
org/10.1016/j.cell.2013.06.027.
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